Improved risk stratification in an adjuvant radiation therapy (ART) eligible cutaneous squamous cell carcinoma (cSCC) patient population by integration of the 40-gene expression profile prognostic test (40-GEP).

Shlomo A. Koyfman,Ashley Wysong,Sarah T. Arron,Ally Khan Somani,Jennifer Siegel,Alison L. Fitzgerald,Sarah J. Kurley,Matthew S. Goldberg,Chrysalyne D. Schmults,Jason G. Newman

Improved risk stratification in an adjuvant radiation therapy (ART) eligible cutaneous squamous cell carcinoma (cSCC) patient population by integration of the 40-gene expression profile prognostic test (40-GEP).

2021

Shlomo A. Koyfman
Ashley Wysong
Sarah T. Arron
Ally Khan Somani
Jennifer Siegel
Alison L. Fitzgerald
Sarah J. Kurley
Matthew S. Goldberg
Chrysalyne D. Schmults
Jason G. Newman

e21589Background: Although cure rates are high for cSCC, an estimated 2-6% of cSCC patients will develop regional/distant metastasis and due to high incidence, mortality levels are similar to melan...

Keywords:

patient population
Medicine
Internal medicine
Cutaneous squamous cell carcinoma
Oncology
risk stratification
adjuvant radiotherapy
Gene expression
high incidence
distant metastasis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations